ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Technical Note

IJPRT. 2012; 2(1): 16-20


Formulation and Evaluation of Novel Gum Based Drug Delivery System of An Antiemetic Drug

Rajnikant Vegada*, A.K. Seth1, Chauhan Sachin, Parth Parikh, Pratik Kheini, Shah Chainesh1, Ramani Vinod. Sumandeep Vidyapeeth, Piparia, Waghodiya.



Abstract
Download PDF Post

The study was to formulate and evaluate medicated chewing gum of meclizine hydrochloride, an antiemetic drug used in nausea, vomiting and motion sickness. The chewing gums were prepared by direct compression method using different ratio of directly compressible gum base (Pharmagum S) in order to obtain optimized formulation. Eight different formulations of chewing gums of meclizine hydrochloride were prepared, which contained various concentration of pharmagum S and Soya powder. The chewing gums which prepared by direct compression method were characterized by pre- compression characters, post compression character, buccal absorption study, drug content and in vitro drug release studies. All the formulations gave satisfactory results in terms of pre compression characters, post compression character, drug content, and in vitro drug release. The best compression characters and 97.88±0.69 % in vitro drug release profile were achieved in formulation MCG5 with a gum and soya powder concentration of 775 mg and 140 mg and FTIR study of optimized MCG5 has shown satisfactory result in terms of drug: polymer compatibility. So MCG5 was taken as optimized batch

Key words: Meclizine hydrocloride, Pharmagum S, Soya powder, Motion sickness







Bibliomed Article Statistics

19
21
23
26
21
23
16
26
17
23
23
17
R
E
A
D
S

20

6

8

8

5

11

18

9

10

8

10

4
D
O
W
N
L
O
A
D
S
080910111201020304050607
20242025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.